Cell Therapy

Is Cancer Immunotherapy More Than Just T Cells?
Research & Development Is Cancer Immunotherapy More Than Just T Cells?

The remarkable success of cancer immunotherapy has long been attributed almost exclusively to the power of T cells, yet a groundbreaking investigation now reveals a previously hidden ally crucial to winning the fight against tumors. This research summary examines a pivotal study that challenges the

New Target Found for Triple-Negative Breast Cancer
Research & Development New Target Found for Triple-Negative Breast Cancer

For the thousands diagnosed each year with triple-negative breast cancer, the treatment path has often been a brutal journey defined by the blunt instrument of chemotherapy, but a groundbreaking discovery is now illuminating a far more precise and strategic path forward. This particularly

New Trials Are Reshaping Bladder Cancer Care
Research & Development New Trials Are Reshaping Bladder Cancer Care

The treatment paradigm for bladder cancer is undergoing a seismic shift, as a new wave of clinical research moves beyond traditional protocols to pioneer a more integrated, intelligent, and immune-focused approach to care. This evolution is not merely about refining existing methods but about

Scientists Use Caffeine to Steer Gene Therapies
Research & Development Scientists Use Caffeine to Steer Gene Therapies

The most advanced medical treatments of our time, including powerful gene and cell therapies, often present a formidable paradox: their immense power to heal is matched by their potential for uncontrolled and harmful side effects. This challenge has driven a quest for a new level of precision, a

Can We Reprogram Our Cells to Defeat Cancer?
Research & Development Can We Reprogram Our Cells to Defeat Cancer?

A new frontier is opening in the fight against cancer and other complex diseases, one that moves beyond the conventional strategy of simply destroying malignant cells and toward the more sophisticated approach of actively reprogramming them. In a significant leap forward for protein therapy, an

Solving the Patient Retention Crisis Before It Starts
Research & Development Solving the Patient Retention Crisis Before It Starts

The persistent challenge of keeping participants engaged in clinical trials has long been treated as a problem that begins only after a patient has consented, but this narrow viewpoint overlooks the vast majority of individuals who disengage before ever setting foot in a clinic. For years, the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later